metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Role of [18F]FDG PET/CT in the evaluation of inflammatory breast cancer: A case ...
Información de la revista
Vol. 43. Núm. 6.
(noviembre - diciembre 2024)
Vol. 43. Núm. 6.
(noviembre - diciembre 2024)
Interesting images
Acceso a texto completo
Role of [18F]FDG PET/CT in the evaluation of inflammatory breast cancer: A case report
Papel de la [18F]FDG PET/TC en la valoración del carcinoma ductal infiltrante de mama inflamatorio: a propósito de un caso
Visitas
11
B. Hervás-Sanza,
Autor para correspondencia
, I.E. Sánchez-Rodrígueza, A. Fernández-Ortegab, P. Perlaza-Jiméneza, M. Cortés-Romeraa, J. Suils-Ramónc
a Nuclear Medicine-PET (IDI), Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
b Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain
c Nuclear Medicine-PET, Vall d'Hebrón University Hospital, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (3)
Mostrar másMostrar menos
Texto completo

We present a case of a supernumerary kidney (SK) fused with the isthmus of a horseshoe kidney (HK) in a child, where the initial suspicion was raised by a dynamic renal scintigraphy with [m99Tc]Tc-MAG3.

A six months’ old female was antenatally diagnosed with a unilateral left sided hydronephrosis in what was thought to be a duplex left kidney at a renal ultrasound scan (US). Her postnatal US (Fig. 1) demonstrated a mild dilatation of the left lower moiety renal pelvis and proximal ureter. In view of those findings she underwent a [m99Tc]Tc-MAG3 dynamic renal scintigraphy to investigate the renal parenchymal function and the drainage. The study was not convincing for a left duplex collecting system but showed a HK and raised the suspicion of the presence of a SK within the isthmus of the HK (Fig. 2).

Figure 1.

A) MIP image (maximum intensity projection) showing a large hyperenhancement in the left breast as well as small axillary and ipsilateral mediastinal deposits in relation to the pathological lymphadenopathies. Moderate bone marrow hypermetabolism, of probable reactive aetiology.

B) PET, CT and PET/CT fusion images, all in axial plane, mediastinal window and in different slices throughout the study, in which the primary tumour can be seen at the level of the breast (66 × 123 x 92 mm (APxTxCC)), with infiltration of the ipsilateral pectoral musculature and hypermetabolic adenopathies at the left axillary level. Extensive inflammatory involvement of the subcutaneous and cutaneous cellular tissue on the left side compared to the contralateral side.

(0.11MB).
Figure 2.

(A) MIP image (maximum intensity projection) showing a significant decrease in the size of the large hyperenhancement located in the left breast.

Slightly intense hypermetabolic foci in the right axilla, attributable to lymphadenopathies of probable tumour aetiology.

(B) PET, CT and PET/CT fusion images in axial plane and mediastinal window, showing a marked decrease in the size and metabolism of the lesion in the left breast (38 × 24 x 38 mm (APxTxCC)), as well as the pectoral infiltration and the ipsilateral axillary lymph nodes.

(0.13MB).

During follow up she was asymptomatic, and no other radiological examinations were requested. However, at 2 years of age, she presented with progressive abdominal distention and fever. An US showed a solid mass in the abdomen. Subsequently, a contrast enhanced CT and MRI scans revealed a heterogeneous mass consistent with a Wilms’ tumour (Fig. 3A,B) and confirmed the presence of a SK arising from the isthmus of a HK, from which the tumoral lesion emerged. Whole genomic sequencing to examine the tumour and germline molecular status was requested; the results are not finalised yet.

Figure 3.

A) MIP image (maximum intensity projection) showing significant progression of the underlying oncological disease (current SUVmax of the left breast of 8.9 g/ml).

B) PET, CT and PET/CT fusion images in axial plane and mediastinal and bone window, showing tumour involvement in both breasts and multiple new bone lesions.

There is also a notable progression of the associated inflammatory component.

(0.13MB).

Multimodal therapy consisted of neoadjuvant chemotherapy followed by a nephron-sparing surgery that revealed a stage III Wilms tumour; and noted the presence of the SK arising from the isthmus of the HK. Post-operative treatment included proton beam therapy and adjuvant chemotherapy. The MRI 3 months at the end of treatment showed no tumour residue or recurrence. The patient remains asymptomatic and in remission two years since Wilms’ tumour was diagnosed.

A SK is a rare congenital renal anomaly.1 Its embryological development is not fully understood; however, it is thought to originate from an aberrant division of the nephrogenic cord into two metanephric blastemas at 5th to 7th week gestation. As a result, two kidneys are formed on the same side, with completely or partially duplicated ureteral buds.1 It can be associated with numerous congenital anomalies, and with an increased incidence of renal malignancies.1

The first imaging modality generally performed to evaluate congenital anomalies of the urinary tract is renal ultrasound, leaving MRI and CT scans if a surgical intervention is planned.2 Dynamic renal scintigraphy with [m99Tc]Tc-MAG3 has a key role in evaluating renal function and also has a role in evaluating renal, pyelocalyceal, ureteral, and bladder anatomy, especially in the pediatric population.3 Additionally, this technique can be used in patients with renal insufficiency who are not suitable for CT-based imaging with contrast, achieving a lower radiation exposure.

Ethical statement

This research work involving human subjects has been conducted in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, ensuring the highest ethical standards. The study aims to include representative human populations in terms of sex, age, and ethnicity, as recommended by these guidelines. The terms “sex” and “gender” have been used accurately and appropriately throughout the manuscript.

Declaration of interest

The authors affirm that they have no financial or personal relationships with any individuals or organizations that could potentially influence or bias their work. The privacy rights of the human subjects involved in this research have been meticulously observed and protected. We affirm our commitment to conducting ethical research and ensuring the welfare and rights of human participants throughout the study process.

References
[1]
MM Patel, HT Le-Petross.
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review.
Chin Clin Oncol, 10 (2021), pp. 56
[2]
DJP Van Uden, MW Prins, S Siesling, JHW de Wilt, CFJM Blanken-Peeters, EHJG Aarntzen.
[18F]FDG PET/CT in the staging of inflammatory breast cancer: a systematic review.
Crit Rev Oncol Hematol, 151 (2020), pp. 102943
[3]
L. Champion, F. Lerebours, J.L. Alberini, E. Fourme, E. Gontier, F. Bertrand, et al.
18F-FDG PET/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer.
J Nucl Med, 56 (2015), pp. 1315-1321
Copyright © 2024. Sociedad Española de Medicina Nuclear e Imagen Molecular
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.remnie.2024.500070
No mostrar más